Analyst Ratings for Vera Therapeutics (VERA)
VERA Rating Summary
VERA Price Target Summary
- Highest: $100.00 (Cantor Fitzgerald)
- Lowest: $34.00 (Leerink)
- Average: $77.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$77.50 (+178%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Avg. $ Target:
$77.50 (+178%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/12/2026 | Leerink | Will Soghikian | New Coverage | Market Perform (N/A) |
34.00 (N/A) |
29.88 (27.88) |
-6.69% | Details |
| 3/10/2026 | Wolfe Research » Updated 6/2/2026 |
Andy Chen | Upgrade | Outperform (Peerperform) |
88.00 (N/A) |
38.97 (27.88) |
-28.46% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
